Ireland, which experienced economic growth during the Covid-19 pandemic due to the presence of large U.S. technology and pharmaceutical companies, is now facing a decline in its economy. The country's gross domestic product (GDP) has contracted by 4.7% compared to the previous year, the largest decline in Europe [8c1c2ddb]. This decline is impacting the overall growth of the eurozone. The latest figures from the Central Statistics Office (CSO) show a 1.8% drop in GDP in the most recent quarter compared to the previous three months [eb1a466f]. While it is important to consider the usual caveats associated with GDP data, the CSO cautions that these figures are part of a new 'frontier' series and should be approached with caution. Despite the decline in GDP, Ireland's real economic growth, although lower than the GDP figures, has remained strong [eb1a466f]. The slowdown in Ireland's growth may be a result of the end of the period of rapid globalization and increasing economic fragmentation. The International Monetary Fund has warned that this fragmentation could disrupt Ireland's economic model [8c1c2ddb]. The closure of the Wyeth Nutrition infant formula factory, which produced for the Chinese market, is an example of the vulnerability faced by Ireland due to its ties with China [8c1c2ddb]. Irish economists had expected a cooling of exports this year, particularly in the pharmaceutical sector, as the world economy reopened and demand for medicines decreased. The decline in exports may also be attributed to company-specific issues and a U.S. ban on semiconductor sales to China [8c1c2ddb]. The difficulties faced by Ireland's tech and pharma businesses have started to impact the jobs market, with the unemployment rate rising to 4.8% in October [8c1c2ddb]. The latest data also shows a fall in the inflation rate, which may help boost consumer confidence [eb1a466f]. These developments in Irish GDP figures highlight the need for a nuanced understanding of economic data and its implications for the overall economy. Ireland's technical recession may turn into a real one due to global economic conditions and the impact of monetary tightening. The country's export-led, multinational-dominated economy has been affected by a fall in pharma exports and weaker global demand. The latest euro zone growth numbers showed a contraction of 0.1% in the third quarter, with Ireland experiencing the biggest fall in GDP. Indicators such as AIB's purchasing managers' index and declining corporation tax receipts also suggest a slowdown. The Department of Finance highlights headwinds including the slowdown in major export markets, the possibility of stickier inflation, and the effects of higher interest rates. The duration and impact of higher interest rates are seen as major economic uncertainties [69b12372]. Ireland, home to large U.S. technology and pharmaceutical companies, experienced annual growth of 10.5% on average between 2020 and 2022 while other economies contracted due to lockdowns [81493864].
Denmark's economy has also contracted due to a decline in pharmaceutical production. The decline in production was caused by the expiration of patents on several drugs, leading to a decrease in exports. The contraction in the economy was also influenced by a decrease in private consumption and investment [2895e3b2]. The decline in pharmaceutical production is expected to continue in the coming years as more patents expire. The Danish government is implementing measures to diversify the economy and reduce its reliance on the pharmaceutical industry. The contraction in the economy is a concern for policymakers as it may lead to job losses and lower tax revenues. The Danish central bank is considering implementing monetary stimulus measures to support economic growth [2895e3b2].